Seroepidemiology Programme Publications

Recent publications that involve the HPA Seroepidemiology Programme include:

2009

IjazS., Vyse A. J., Morgan D., Pebody R. G., Tedder R. S., Brown D. Indigenous hepatitis E virus infection in England: more common than it seems.  J Clin Virol 2009; 44: 272-76

Vyse A. J., Hesketh L. M., Pebody R. G. The burden of infection with cytomegalovirus in England and Wales: how many women are infected in pregnancy? Epidemiol Infect 2009; 137: 526-33

2007

Vyse A. J., Andrews N. J., Hesketh L. M., Pebody R. G. The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiol Infect 2007; 135: 1354-62

Trotter C., Findlow J., Balmer P., Holland A., Barchla R., Hamer N., Andrews N., Miller E., Borrow R.  Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.  Clin Vacc Immunol 2007; 14: 863-68.

Jit M., Vyse A., Borrow R., Pebody R., Soldan K., Miller E.  Prevalence of human papillomavirus antibodies in young female subjects in England.  British Journal of Cancer 2007; 97: 989-91.

Balmer P., Borrow R., Findlow J., Warrington R., Frankland S., Waight P., George R., Andrews N., Miller E.  Age-stratified prevalences of pneumococcal serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine.  Clin Vacc Immunol 2007; 14: 1442-50.

2004

Vyse AJ, Gay NJ, Hesketh L, Morgan-Capner P, Miller E. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect 2004; 132: 1129-34.

2003

Trotter C'; Borrow R., Andrews N., Miller E.  Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era.  Vaccine 2003; 21: 1094-98

Trotter C., McVernon J., Andrews N.J., Burrage M., Ramsay M.E.  Antibody to Haemophilus Influenzae type b after routing and catch-up vaccination.  Lancet 2003; 361: 1523-24.

2002

Balogun MA, Ramsay ME, Hesketh LM, Andrews N, Osborne KP, Gay NJ, Morgan-Capner P. The prevalence of hepatitis C in England and Wales. J Infect 2002; 45: 219-26.

Knowles WA, Pipkin P, Andrews N, Vyse AJ, Minor P, Brown DWG, Miller E. Population based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2002; 71: 115-23.

Morris MC, Edmunds JW, Hesketh LM, Vyse AJ, Miller E, Morgan-Capner P, Brown DWG. Sero-epidemiological patterns of Epstein-Barr and Herpes Simplex (HSV-1 and HSV-2) viruses in England and Wales. J Med Virol 2002; 67: 522-7.

Morris MC, Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. The changing epidemiological pattern of hepatitis A in England and Wales. Epidemiol Infect 2002; 128: 457-63.

Pebody RG, Gay NJ, Hesketh LM, Vyse A, Morgan-Capner P, Brown DW, Litton P, Miller E. Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine 2002; 20: 1134-40.

Vyse AJ, Gay NJ, White JM, Ramsay ME, Brown DWG, Cohen BJ, Hesketh LM, Morgan-Capner P, Miller E. Evolution of surveillance of measles, mumps and rubella in England and Wales - providing the platform for evidence based vaccination policy. Epidemiol Rev 2002; 24: 125-36.

Vyse AJ, Gay NJ, Hesketh LM, Andrews NJ, Marshall B, Thomas HIJ, Morgan-Capner P, Miller E. The burden of Helicobacter pylori infection in England and Wales. Epidemiol Infect 2002; 128: 411-7.

2001

Maple PA, Jones CS, Wall EC, Vyse A, Edmunds WJ, Andrews NJ, Miller E. Immunity to diphtheria and tetanus in England and Wales. Vaccine 2001; 19: 167-73.

Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, Brown DW. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000; 76: 183-7.

Last reviewed: 17 February 2010